CompoAtlas

Apropos® C košļājamās tabletes ar apelsīnu garšu (Paziņots 2011.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000322/2011
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Magnum Medical SIA
Manufacturer
QUIDNOVI S.P.A
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
4 tabletes dienā
Published pack size
tabletes pa 0,7g
Published packaging
60 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Ehinācijas saknes sausais ekstrakts 1,42%plants ; Ehinācijas saknes sausais ekstrakts 1,42% ; Echinacea angustifolia ; 40 ; mgechinacea angustifoliaPlant
Mārsila lapu sausais ekstrakts 0,7%plants ; Mārsila lapu sausais ekstrakts 0,7% ; Thymus vulgaris ; 20 ; mgthymus vulgarisPlant
Acerolas augļu sausais ekstrakts (kas satur 50 mg vitamīna C)plants ; Acerolas augļu sausais ekstrakts (kas satur 50 mg vitamīna C) ; Malpighia punicifolia ; 200 ; mgmalpighia punicifoliaPlant
Maltīts (E965)otherIngredients ; Maltīts (E965)Listed as food additive E 965(i) (EU Union list)Role not identified
Sorbīts (E420)otherIngredients ; Sorbīts (E420)Listed as food additive E 420(i) (EU Union list)Role not identified
FruktozeotherIngredients ; FruktozeNot recognisedRole not identified
Sausais propolisa ekstraktsotherIngredients ; Sausais propolisa ekstrakts ; 60 ; mgNot recognisedRole not identified
Apelsīnu aromatizētājsotherIngredients ; Apelsīnu aromatizētājsNot recognisedRole not identified
Taukskābju mono un diglicerīdi (E 471)otherIngredients ; Taukskābju mono un diglicerīdi (E 471)Listed as food additive E 471 (EU Union list)Role not identified
Augu izcelsmes magnija stearāts (E470b)otherIngredients ; Augu izcelsmes magnija stearāts (E470b)Listed as food additive E 470b (EU Union list)Role not identified
Silīcija dioksīds (E551)otherIngredients ; Silīcija dioksīds (E551)Listed as food additive E 551 (EU Union list)Role not identified
Sojas lecitīns (E322)otherIngredients ; Sojas lecitīns (E322)Listed as food additive E 322 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Itālija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ehinācijas saknes sausais ekstrakts 1,42%
    Read the warning, when it applies and the studies cited

    ECHINACEA- ECHINACEA ANGUSTIFOLIA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (Gardner and McGuffin 2013; Brinker 2010).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 28 March 2025

  • Mārsila lapu sausais ekstrakts 0,7%
    Read the warning, when it applies and the studies cited

    THYME - THYMUS VULGARIS - Buccal

    Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    THYME - THYMUS VULGARIS - Oral

    Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Health Canada monograph dated 26 June 2026

    THYME - THYMUS VULGARIS - Topical

    Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Apropos® C košļājamās tabletes ar apelsīnu garšu (Paziņots 2011.)”, https://compoatlas.com/en/supplements/latvia/3170-apropos-c-koslajamas-tabletes-ar-apelsinu-garsu-pazinots-201, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line